References
- Kamei T, Noro H, Yabe K, Makino S. [Statistical observation of unilateral total deafness and characteristics of unilateral total deafness among young children with tendency toward dizziness]. Jibiinkoka 1971;43:349–58.
- Nadol JBJr, Weiss AD, Parker SW. Vertigo of delayed onset after sudden deafness. Ann Otol Rhinol Laryngol 1975;84:841–6.
- Wolfson RJ, Leiberman A. Unilateral deafness with subsequent vertigo. Laryngoscope 1975;85:1762–6.
- Schuknecht HF. Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol 1978;87:743–8.
- Huang TS, Lin CC. Delayed endolymphatic hydrops: study and review of clinical implications and surgical treatment. Ear Nose Throat J 2001;80:76–8; 81–2, 4 passim.
- Hicks GW, Wright JW3rd. Delayed endolymphatic hydrops: a review of 15 cases. Laryngoscope 1988;98:840–5.
- Shojaku H, Watanabe Y, Mineta H, Aoki M, Tsubota M, Watanabe K, et al. Long-term effects of the Meniett device in Japanese patients with Meniere’s disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan. Acta Otolaryngol 2011;131:277–83.
- Bauer PW, MacDonald CB, Cox LC. Intratympanic gentamicin therapy for vertigo in nonserviceable ears. Am J Otolaryngol 2001;22:111–15.
- Sajjadi H, Paparella MM. Meniere’s disease. Lancet 2008;372:406–14.
- Garduno-Anaya MA, Couthino De Toledo H, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere’s disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005;133:285–94.
- Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Meniere’s disease. Am J Otol 1999;20:357–63.
- Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière’s disease. American Academy of Otolaryngology-Head and Neck Foundation. Inc. Otolaryngol Head Neck Surg 1995;113:181–5.
- Shojaku H, Watanabe Y, Takeda N, Ikezono T, Takahashi M, Kakigi A, et al. Clinical characteristics of delayed endolymphatic hydrops in Japan: a nationwide survey by the Peripheral Vestibular Disorder Research Committee of Japan. Acta Otolaryngol 2010;130:1135–40.
- Egami N, Ushio M, Yamasoba T, Murofushi T, Iwasaki S. Indication of the side of delayed endolymphatic hydrops by vestibular evoked myogenic potential and caloric test. ORL J Otorhinolaryngol Relat Spec 2010;72:242–6.
- Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, et al. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope 2007;117:415–20.
- Kamei T. Delayed endolymphatic hydrops as a clinical entity. Int Tinnitus J 2004;10:137–43.
- Albernaz PL. Unusual cases of delayed endolymphatic hydrops. Acta Otolaryngol 2007;127:355–9.
- Nevoux J, Viengchareun S, Lema I, Lecoq AL, Ferrary E, Lombes M. Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation. Pflugers Arch 2014; Epub ahead of print.
- Harris JP, Aframian D. Role of autoimmunity in contralateral delayed endolymphatic hydrops. Am J Otol 1994;15:710–16.
- Schuknecht HF, Suzuka Y, Zimmermann C. Delayed endolymphatic hydrops and its relationship to Meniere’s disease. Ann Otol Rhinol Laryngol 1990;99:843–53.